USD
+$0.00
(+0.00%
)At Close (As of Sep 3, 2025)
$3.22M
Market Cap
-
P/E Ratio
-60.23
EPS
$14.63
52 Week High
$2.90
52 Week Low
LIFE SCIENCES
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$206K |
Total Revenue | $0 |
Cost Of Revenue | $206K |
Costof Goods And Services Sold | $206K |
Operating Income | -$18M |
Selling General And Administrative | $7.1M |
Research And Development | $3.2M |
Operating Expenses | $11M |
Investment Income Net | - |
Net Interest Income | -$7.3M |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $206K |
Income Before Tax | -$12M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$12M |
Comprehensive Income Net Of Tax | - |
Ebit | -$12M |
Ebitda | -$11M |
Net Income | -$12M |
Field | Value (USD) |
---|---|
Total Assets | $4.5M |
Total Current Assets | $3.4M |
Cash And Cash Equivalents At Carrying Value | $3.2M |
Cash And Short Term Investments | $3.2M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $1M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $204K |
Other Non Current Assets | - |
Total Liabilities | $1.9M |
Total Current Liabilities | $605K |
Current Accounts Payable | $270K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $97K |
Total Non Current Liabilities | $1.3M |
Capital Lease Obligations | $584K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $584K |
Other Current Liabilities | $239K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $2.6M |
Treasury Stock | - |
Retained Earnings | -$103M |
Common Stock | $53 |
Common Stock Shares Outstanding | $1.1M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$7.4M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $206K |
Capital Expenditures | $16K |
Change In Receivables | - |
Change In Inventory | $236K |
Profit Loss | - |
Cashflow From Investment | -$13K |
Cashflow From Financing | $7.8M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $5.2K |
Dividend Payout Common Stock | $5.2K |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$12M |
Field | Value (USD) |
---|---|
Gross Profit | -$206K |
Total Revenue | $0 |
Cost Of Revenue | $206K |
Costof Goods And Services Sold | $206K |
Operating Income | -$18M |
Selling General And Administrative | $7.1M |
Research And Development | $3.2M |
Operating Expenses | $11M |
Investment Income Net | - |
Net Interest Income | -$7.3M |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $206K |
Income Before Tax | -$12M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$12M |
Comprehensive Income Net Of Tax | - |
Ebit | -$12M |
Ebitda | -$11M |
Net Income | -$12M |
Sector: LIFE SCIENCES
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company is headquartered in Ann Arbor, Michigan.